Journal articles

2022

ref_biblio

Amélie Descheemaeker, Hervé Poras, Michel Wurm, Philippe Luccarini, Tanja Ouimet, et al.. Dual enkephalinase inhibitor PL37 as a potential novel treatment of migraine: evidence from a rat model. Brain - A Journal of Neurology , 2022, 145 (8), ⟨10.1093/brain/awac139⟩. ⟨hal-03643577⟩

Accès au texte intégral et bibtex

ref_biblio

Eric Ducret, Florian Jacquot, Amélie Descheemaeker, Radhouane Dallel, Alain Artola. Chronic facial inflammatory pain-induced anxiety is associated with bilateral deactivation of the rostral anterior cingulate cortex. Brain Research Bulletin, 2022, 184, pp.88-98. ⟨10.1016/j.brainresbull.2022.03.012⟩. ⟨hal-03646725⟩

Accès au texte intégral et bibtex

ref_biblio

Noëmie Mermet-Joret, Cristina Alba-Delgado, Amélie Descheemaeker, Francois Gabrielli, Radhouane Dallel, et al.. Postnatal development of inner lamina II interneurons of the rat medullary dorsal horn. Pain, 2022, 163 (5), pp.984-998. ⟨10.1097/j.pain.0000000000002459⟩. ⟨hal-04487389⟩

Accès au bibtex

2021

ref_biblio

Alexia Visseq, Amélie Descheemaeker, Karine Hérault, Francis Giraud, Isabelle Abrunhosa-Thomas, et al.. Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia. European Journal of Medicinal Chemistry, 2021, 225, pp.113748. ⟨10.1016/j.ejmech.2021.113748⟩. ⟨hal-03334145⟩

Accès au texte intégral et bibtex

2020

ref_biblio

Alexia Visseq, Amélie Descheemaeker, Nicolas Pinto-Pardo, Lionel Nauton, Vincent Thery, et al.. Pyridin-2(1H)one derivatives: A possible new class of therapeutics for mechanical allodynia. European Journal of Medicinal Chemistry, 2020, 187, pp.111917. ⟨10.1016/j.ejmech.2019.111917⟩. ⟨hal-02444268⟩

Accès au texte intégral et bibtex

2017

ref_biblio

Radhouane Dallel, Amélie Descheemaeker, Philippe Luccarini. Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.. Cephalalgia, 2017, ⟨10.1177/0333102417714032⟩. ⟨hal-01680712⟩

Accès au bibtex

ref_biblio

José Maria Ramos Flores, Laurent Devoize, Amélie Descheemaeker, Jean-Louis Molat, Philippe Luccarini, et al.. The nitric oxide donor, isosorbide dinitrate, induces a cephalic cutaneous hypersensitivity, associated with sensitization of the medullary dorsal horn: Nitric oxide donors induced central sensitization. Neuroscience, 2017, ⟨10.1016/j.neuroscience.2016.12.028⟩. ⟨inserm-01458345⟩

Accès au texte intégral et bibtex

2016

ref_biblio

Yan Lefèvre, Aurélie Amadio, Peggy Vincent, Amélie Descheemaeker, Stéphane H.R. Oliet, et al.. Effects of glia metabolism inhibition on nociceptive behavioral testing in rats. Data in Brief, 2016, 7, pp.372 - 375. ⟨10.1016/j.dib.2016.02.043⟩. ⟨hal-03126326⟩

Accès au texte intégral et bibtex

Conference papers

2023

ref_biblio

Pauline Murail, Amélie Descheemaeker, Gisela da Silva Borges, Nicolas Pinto-Pardo, Alexia Visseq, et al.. Pyridin-2(1H)one derivatives: A new class of therapeutics for trigeminal pain. International Headache Congress, Sep 2023, séoul, France. ⟨hal-04213873⟩

Accès au bibtex

2019

ref_biblio

A. Visseq, A. Descheemaeker, L. Nauton, V. Théry, F. Giraud, et al.. Design and synthesis of new nitrogen-containing heterocycles for the treatment of mechanical allodynia.. Bioheterocycle 2019, XVIII International Conference on Heterocycles in Bioorganic Chemistry, Jun 2019, Gand, Belgium. ⟨hal-02288758⟩

Accès au bibtex

Patents

2021

ref_biblio

R. Dallel, A. Artola, A. Descheemaeker, F. Anizon, I. Thomas, et al.. Novel pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain.. France, Patent n° : WO2021064186. 2021. ⟨hal-03212911⟩

Accès au bibtex